COVID treatment update: Answers to what HPs are asking NPS MedicineWise speaks with members of the National COVID-19 Clinical Evidence Taskforce Guidelines Leadership Group, who provide an update on the new antiviral treatments and answer some frequently asked questions.
First COVID-19 antiviral receives PBS funding GPs can now prescribe molnupiravir for COVID-positive adult patients at risk of developing severe disease.
COVID-19 antiviral pills to be reserved primarily for the unvaccinated Despite TGA approval last month, the two new COVID-19 treatments developed by Pfizer and Merck will not be widely available for prescription in the short-term.
What is Australia’s potential new COVID treatment? Half a million doses of the oral antiviral candidate could become available from next year, pending TGA approval.
GPs could soon have an antiviral pill to treat COVID-19 A new oral treatment reduces the risk of hospitalisation and death due to COVID by 50%, research suggests.
Gold standard trial finds remdesivir shortens duration of COVID-19 The results have confirmed doctors’ experiences of treating COVID patients in Australia.
COVID-19 research receives $66 million boost The funding injection will target four areas of research in the quest for a vaccine and preparation for future pandemics.
Remdesivir and COVID-19: What GPs need to know It has become the first therapy for COVID-19 to receive FDA approval for emergency use – but evidence of its effectiveness remains mixed.